Literature DB >> 19538364

The expression of SnoN in normal human skin and cutaneous keratinous neoplasms.

Xiaoyong Zhang1, Kiyofumi Egawa, Yong Xie, Hironobu Ihn.   

Abstract

BACKGROUND: SnoN is a member of the ski family of proto-oncogenes. It has been revealed that SnoN plays a role in the regulation of cell growth, vertebrate development, and tumorigenesis. This study investigated the expression and significance of SnoN protein in normal human skin and in the development of seborrheic keratosis (SK), basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) of the skin.
METHODS: Six frozen sections of normal human skin, three of SK (acanthotic type), six of BCC, six of intraepidermal SCC (actinic keratosis, AK), and six each of poorly and well-differentiated SCC were immunohistochemically stained with a polyclonal antibody against SnoN.
RESULTS: In normal epidermis, strong positive staining was observed in the suprabasal layers, whereas the basal cell layer was entirely unstained. Expression was observed in tumor cells with a squamoid phenotype in SK, but not in BCC. In intraepidermal SCC, although a strong signal was seen in the well-differentiated keratinocytes of the superficial epidermal cell layers, no signal was seen in the poorly differentiated atypical cells situated in the lower epidermis. In invasive SCC, a few scattered cells were positive for SnoN in the well-differentiated sample, but much larger numbers of positive cells were observed in the poorly differentiated sample.
CONCLUSIONS: On the basis of our results, it is suggested that SnoN is involved in differentiation in normal skin and benign and nonmetastatic skin tumors, but plays a proto-oncogenic role in undifferentiated SCC.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19538364     DOI: 10.1111/j.1365-4632.2009.03685.x

Source DB:  PubMed          Journal:  Int J Dermatol        ISSN: 0011-9059            Impact factor:   2.736


  9 in total

Review 1.  New molecular medicine-based scar management strategies.

Authors:  Anna I Arno; Gerd G Gauglitz; Juan P Barret; Marc G Jeschke
Journal:  Burns       Date:  2014-01-15       Impact factor: 2.744

Review 2.  SnoN signaling in proliferating cells and postmitotic neurons.

Authors:  Shirin Bonni; Azad Bonni
Journal:  FEBS Lett       Date:  2012-03-08       Impact factor: 4.124

Review 3.  SnoN in regulation of embryonic development and tissue morphogenesis.

Authors:  Qingwei Zhu; Kunxin Luo
Journal:  FEBS Lett       Date:  2012-03-10       Impact factor: 4.124

Review 4.  SnoN in mammalian development, function and diseases.

Authors:  Nadine S Jahchan; Kunxin Luo
Journal:  Curr Opin Pharmacol       Date:  2010-09-06       Impact factor: 5.547

5.  SnoN: bridging neurobiology and cancer biology.

Authors:  I Pot; Y Ikeuchi; A Bonni; S Bonni
Journal:  Curr Mol Med       Date:  2010-10       Impact factor: 2.222

6.  SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.

Authors:  Gui-Fang Sun; Hong-Chang Li; Yue-Ping Zhan; Xiao-Fen Zhang; Li-Yun Pan; Ya-Feng Chen; Ke Xu; Dian-Xu Feng
Journal:  Lab Invest       Date:  2019-08-13       Impact factor: 5.662

7.  Expression profiles of SnoN in normal and cancerous human tissues support its tumor suppressor role in human cancer.

Authors:  Nadine S Jahchan; Gaoliang Ouyang; Kunxin Luo
Journal:  PLoS One       Date:  2013-02-13       Impact factor: 3.240

8.  The influence of SnoN gene silencing by siRNA on the cell proliferation and apoptosis of human pancreatic cancer cells.

Authors:  Chengli Liu; Hui Zhang; Xiaoxia Zang; Cheng Wang; Yalin Kong; Hongyi Zhang
Journal:  Diagn Pathol       Date:  2015-04-18       Impact factor: 2.644

9.  Transcriptional cofactors Ski and SnoN are major regulators of the TGF-β/Smad signaling pathway in health and disease.

Authors:  Angeles C Tecalco-Cruz; Diana G Ríos-López; Genaro Vázquez-Victorio; Reyna E Rosales-Alvarez; Marina Macías-Silva
Journal:  Signal Transduct Target Ther       Date:  2018-06-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.